Verizon retirees have sued the phone company because it's planning to transfer the responsibility of paying their pensions to an insurance company, where they will have weaker legal protection.
The election behind them, U.S. investors dumped stocks Wednesday and turned their focus to a world of problems economically harmful tax increases and spending cuts at home and a deepening recession in Europe.
A possible Alzheimer's disease treatment from drugmaker Eli Lilly showed some promise in late-stage research, even though the drug failed to slow a form of mental decline in two separate studies of patients with the mind-robbing condition.
U.S. stocks opened lower Thursday after the government said the number of people seeking unemployment claims rose last week, evidence of an uneven recovery in the job market.
If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.
Pharmacy operator Walgreen Co. said Thursday that a key revenue metric fell 10 percent in June, as it took another step to battle a sales slump by acquiring a regional drugstore chain.
The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to be a boon to most of the health care industry by making coverage more affordable for millions of uninsured Americans.